SCHEMBL8096066

SCHEMBL8096066

CCOc1nc(OCC)n(Cc2ccc(Cc3ccccc3C(=O)O)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
AGTR1 P30556 5/20 0.40
AGTR2 P50052 5/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MAPK8 P45983 1/20 0.39
KMT2A Q03164 1/20 0.39
ABCB11 O95342 1/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADRB3 P13945 1/20 0.39
ADRA2B P18089 1/20 0.39
SLC6A2 P23975 1/20 0.39
TBXAS1 P24557 1/20 0.39
HTR2C P28335 1/20 0.39
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8105468 0.89 TSHR (0.44) TSHRAGTR1AGTR2CA1CA2
SCHEMBL8105788 0.89 TSHR (0.43) TSHRAGTR1AGTR2MAPK8
SCHEMBL6005872 0.86 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL8103249 0.82 TSHR (0.45) TSHRAGTR1AGTR2CA1CA2
SCHEMBL9737993 0.80 KMT2A (0.47) AGTR1AGTR2KMT2AABCB11EGFR
SCHEMBL8105171 0.77 PPARG (0.48) PPARGLTB4R2
SCHEMBL6007240 0.75 AGTR1 (0.52) AGTR1AGTR2PPARG
SCHEMBL6005849 0.75 AGTR1 (0.55) AGTR1AGTR2PPARG
SCHEMBL6004912 0.74 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL6007482 0.74 AGTR1 (0.60) AGTR1AGTR2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed